Syngene Updates Exchanges on Order Implementing NFAC Ruling in Tax Case

Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an announcement.

Syngene International Limited has notified stock exchanges that it has received an order dated February 6, 2026, giving effect to an earlier decision by the National Faceless Appeal Centre for assessment year 2016-17, which was communicated to the company by email on March 28, 2026. This update follows a series of tax-related proceedings, including a writ petition before the High Court of Karnataka over refund adjustments for earlier assessment years and a partially favorable NFAC order, and indicates continued resolution of legacy tax disputes that are relevant for investors tracking the company’s regulatory and financial exposures.

The company confirmed that required details on this matter have been provided to exchanges in the prescribed Form A under SEBI’s disclosure regulations and recent circulars, and declared that the information is true and complete to the best of management’s knowledge. By formally recording this tax litigation development and directing stakeholders to its website for further information, Syngene underscores its compliance with enhanced transparency norms, which may help reduce uncertainty around pending tax matters and support informed decision-making by shareholders and other market participants.

More about Syngene International Ltd.

Syngene International Limited is an India-based contract research, development and manufacturing organization serving the global pharmaceutical, biotechnology and other life sciences industries. The company operates from its facilities in Biocon SEZ and Biocon Park in Bengaluru, providing integrated discovery, development and manufacturing services to innovator companies focused on drug development and related research.

Average Trading Volume: 99,937

Technical Sentiment Signal: Sell

Current Market Cap: 166.8B INR

Find detailed analytics on SYNGENE stock on TipRanks’ Stock Analysis page.